RTS,S/AS02A Malaria Vaccine-Induced IgG Responses Equally Recognize Native-Like Fucosylated and Nonfucosylated Plasmodium falciparum Circumsporozoite Proteins

Author:

Jairoce Chenjerai12,Macià Dídac13,Torres-Yaguana Jorge P1,Mayer Leonie14,Vidal Marta1,Santano Rebeca1,Hurtado-Guerrero Ramón567,Reiter Karine8,Narum David L8,Lopez-Gutierrez Borja9,Hamerly Timothy9,Sacarlal Jahit2,Aguilar Ruth1,Dinglasan Rhoel R9,Moncunill Gemma13,Izquierdo Luis13,Dobaño Carlota13ORCID

Affiliation:

1. Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona , Barcelona, Catalonia , Spain

2. Centro de Investigação em Saúde de Manhiça , Maputo , Mozambique

3. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) , Barcelona , Spain

4. Université Claude Bernard Lyon 1, Université de Lyon , Villeurbanne , France

5. Institute of Biocomputation and Physics of Complex Systems, University of Zaragoza , Zaragoza , Spain

6. Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen , Copenhagen , Denmark

7. Fundación Agencia Aragonesa para la Investigación y el Desarrollo , Zaragoza , Spain

8. Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland , USA

9. Emerging Pathogens Institute, Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida , Gainesville, Florida , USA

Abstract

Abstract   The RTS,S/AS02A malaria vaccine is based on the Plasmodium falciparum circumsporozoite protein (PfCSP), which is O-fucosylated on the sporozoite surface. We determined whether RTS,S/AS02A-induced immunoglobulin G (IgG) antibodies recognize vaccine-like nonfucosylated PfCSP better than native-like fucosylated PfCSP. Similar to previous vaccine trials, RTS,S/AS02A vaccination induced high anti-PfCSP IgG levels associated with malaria protection. IgG recognition of nonfucosylated and fucosylated PfCSP was equivalent, suggesting that PfCSP fucosylation does not affect antibody recognition. Clinical Trials Registration NCT00197041.

Funder

European

Social Fund

European Commission

Fondation Mérieux

Ministry of Science and Innovation, Spain

European Social Fund

PATH

GlaxoSmithKline Biologicals S.A

National Institutes of Health, National Institute of Allergy and Infectious Diseases

Spanish Agency for International Cooperation and Development

Spanish Ministry of Science and Innovation

Generalitat de Catalunya

Fundación Ramón Areces

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3